ASCP WEBINAR The Utilisation, Effectiveness & Safety of Smoking Cessation Pharmacotherapies During Pregnancy: An Australian Population-Based Study

This NHMRC-funded research used linked pharmaceutical claims and administrative health data for all women who gave birth in New South Wales and Western Australia between 2004 and 2012 to examine the extent to which prescription NRT patches, bupropion and varenicline are used during pregnancy. To examine the effectiveness of these medicines during pregnancy, the smoking cessation rates associated with varenicline relative to NRT patch use was measured. The risk and benefits associated with these medicines in pregnancy was assessed by comparing the rate of adverse birth outcomes among women who used prescription NRT patches, bupropion or varenicline with the rate among women who smoked but did not receive any of these medicines.

 https://us02web.zoom.us/webinar/register/WN_GAWMPIT2S2C-6I7rRhH_3Q